July 24, 2018 BY Valentina Kirilova
Shenzhen Stock Exchange publicly denounces Changsheng Bio-technology
The State Drug Administration notified on July 15 that Changchun Changsheng Bio-technology Co., Ltd. (Changchun Changsheng), subsidiary of Changsheng Bio-technology Co. Ltd. (the Company), was found violating relevant laws and regulations while producing freeze-dried rabies vaccines for human use. According to the notification, the State Drug Administration has launched an investigation on Changchun Changsheng and…
Read more